Edwards Lifesciences EW
NYSE EW
$86.16 -0.56 (-0.65%)
As of: Sep 9, 2026 · 3:59 PM EDT

Edwards Lifesciences (EW) FCF Margin Growth (3y) (2012 - 2026)

Analysis

Edwards Lifesciences (EW) FCF Margin Growth (3y) (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 884.00
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 503.00
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 646.00
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 534.00
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 919.00
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 3,472.00
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 353.00
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -97.00
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 60.00
10 Zimmer Biomet Holdings 18.20 Bn 17.79 Bn 1.54 Bn 468.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3,472.00
Mar 31, 2026 -2,196.00
Dec 31, 2025 -2,723.00
Sep 30, 2025 1,428.00
Jun 30, 2025 -532.00
Mar 31, 2025 -56.00
Dec 31, 2024 -3,414.00
Sep 30, 2024 -1,382.00
Jun 30, 2024 -1,231.00
Mar 31, 2024 -2,492.00
Dec 31, 2023 -2,024.00
Sep 30, 2023 1,876.00
Jun 30, 2023 -1,442.00
Mar 31, 2023 962.00
Dec 31, 2022 2,153.00
Sep 30, 2022 -1,406.00
Jun 30, 2022 -441.00
Mar 31, 2022 2,055.00
Dec 31, 2021 -272.00
Sep 30, 2021 759.00